Subscribe To
MEDXF / Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
MEDXF News
By Newsfile Corp
June 14, 2023
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2023 Conference Call
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 14, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conferenc more_horizontal
By GlobeNewsWire
April 18, 2023
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company managemen more_horizontal
By Seeking Alpha
February 9, 2023
Medexus Pharmaceuticals Inc. (MEDXF) Q3 2023 Earnings Call Transcript
Medexus Pharmaceuticals Inc Q3 2023 Results Conference Call February 9, 2023 8:00 AM ET Company Participants Victoria Rutherford - Investor Relations more_horizontal
By GlobeNewsWire
January 31, 2023
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
TORONTO and CHICAGO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call a more_horizontal
By Seeking Alpha
November 13, 2022
Medexus Pharmaceuticals Inc. (MEDXF) Q2 2023 Earnings Call Transcript
Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q2 2023 Earnings Conference Call November 9, 2022 8:00 AM ET Company Participants Victoria Rutherford - Inv more_horizontal
By Seeking Alpha
February 10, 2022
Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript
Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript more_horizontal
By Seeking Alpha
February 10, 2022
Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript
Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript more_horizontal
By Seeking Alpha
February 10, 2022
Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript
Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q3 2022 Results - Earnings Call Transcript more_horizontal